The antifungal activity of mupirocin

J Antimicrob Chemother. 1999 Apr;43(4):579-82. doi: 10.1093/jac/43.4.579.

Abstract

The antibacterial agent mupirocin (pseudomonic acid A) is used as a topical agent in the treatment of superficial infections by Gram-positive bacteria, particularly Staphylococcus aureus. However, we demonstrate here that the compound also inhibits the growth of a number of pathogenic fungi in vitro, including a range of dermatophytes and Pityrosporum spp. It inhibited the incorporation of amino acids and precursors of RNA, but not that of acetate, by Trichophyton mentagrophytes. It also inhibited the isoleucyl-tRNA synthetase from Candida albicans, indicating a mechanism of action similar to that in bacteria. When administered topically, mupirocin was efficacious in a T. mentagrophytes ringworm model in guinea pigs. These results suggest that mupirocin could have clinical utility for superficial infections caused by dermatophytes.

MeSH terms

  • Administration, Topical
  • Animals
  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use
  • Candida albicans / drug effects
  • Candida albicans / enzymology
  • Female
  • Fungi / drug effects*
  • Guinea Pigs
  • Isoleucine-tRNA Ligase / antagonists & inhibitors
  • Isoleucine-tRNA Ligase / metabolism
  • Malassezia / drug effects
  • Microbial Sensitivity Tests
  • Mupirocin / pharmacology*
  • Mupirocin / therapeutic use
  • Tinea / drug therapy*
  • Tinea / microbiology
  • Trichophyton / drug effects

Substances

  • Antifungal Agents
  • Mupirocin
  • Isoleucine-tRNA Ligase